Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
1066 On Other Exchanges
Symbol
Exchange
1066 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shandong weigao gp medical-h (1066) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANDONG WEIGAO GP MEDICAL-H (1066)

Related News

No related news articles were found.

shandong weigao gp medical-h (1066) Related Businessweek News

No Related Businessweek News Found

shandong weigao gp medical-h (1066) Details

Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of medical devices under the Jierui and Wego Ortho brands in the People’s Republic of China and internationally. The company operates through Single Use Medical Device Products, Orthopaedic Products, and Blood Purification Products divisions. It offers single use medical consumables and materials, which include infusion sets, syringes, blood bags and blood component segregator consumables, blood sampling consumables, pre-filled syringes, dental consumables, anesthetic consumables, and medical PVC granules and non-PVC granules, as well as medical needle products comprising intravenous, syringe, intravenous catheter, blood sampling, and irregular needles. The company also provides orthopaedic materials and tools comprising therapeutic consumables, such as steel plates, screws, spinal series consumables, and artificial joints consumables. In addition, it offers blood purification consumables, including renal consumables, such as puncture needles, blood circuits, dialysis equipment, and immunity adsorption products for the treatment of immune system diseases; and other LDL adsorption, internal toxin adsorption, and hepatitis B adsorption products, as well as heart eluting stents, including drug eluting stents and balloon catheters. Further, the company is involved in trading medical products; providing logistics and storage services; and manufacturing moulds, and industrial automatic equipment and parts, as well as provides medical management software development and related technical consulting services. It sells its products to healthcare organizations and distributors, including hospitals, blood stations, and other medical units. The company was founded in 2000 and is based in Weihai, the People’s Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.

9,847 Employees
Last Reported Date: 03/18/15
Founded in 2000

shandong weigao gp medical-h (1066) Top Compensated Officers

Vice Chairman, General Manager, Compliance Of...
Total Annual Compensation: CNY1.2M
Executive Director
Total Annual Compensation: CNY900.0K
Executive Director
Total Annual Compensation: CNY666.0K
Deputy General Manager of General Affairs and...
Total Annual Compensation: CNY954.0K
Sales Manager and Supervisor
Total Annual Compensation: CNY457.0K
Compensation as of Fiscal Year 2013.

shandong weigao gp medical-h (1066) Key Developments

Shandong Weigao Group Medical Polymer Co., Limited Recommends Final Dividend for the Year Ended December 31, 2014

The Directors of Shandong Weigao Group Medical Polymer Co., Limited recommended the payment of a final dividend of RMB 0.035 per share for the year ended December 31, 2014 (2013: RMB 0.031), which is subject to the approval by the shareholders of the company at the forthcoming general meeting.

Shandong Weigao Group Medical Polymer Company Limited Reports Unaudited Consolidated Earnings Results for the Year Ended December 31, 2014

Shandong Weigao Group Medical Polymer Company Limited reported unaudited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenue of RMB 5,277,827,000 compared to RMB 4,613,310,000 a year ago. Profit before taxation was RMB 1,275,664,000 compared to RMB 544,154,000 a year ago. Profit for the year was RMB 1,094,820,000 compared to RMB 387,679,000 a year ago. Profit for the year attributable to owners of the Company was RMB 1,084,948,000 compared to RMB 387,984,000 a year ago. Basic earnings per share was RMB 0.24 compared to RMB 0.09 a year ago. Net cash flow from operating activities of the Group amounted to approximately RMB 711,219,000. The Group has maintained a sound cash flow position.

Shandong Weigao Group Medical Polymer Co., Limited, 2014 Earnings Call, Mar 18, 2015

Shandong Weigao Group Medical Polymer Co., Limited, 2014 Earnings Call, Mar 18, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1066:HK $6.68 HKD +0.18

1066 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1066.
View Industry Companies
 

Industry Analysis

1066

Industry Average

Valuation 1066 Industry Range
Price/Earnings 22.1x
Price/Sales 4.5x
Price/Book 2.4x
Price/Cash Flow 22.1x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG WEIGAO GP MEDICAL-H, please visit www.weigaogroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.